Long Non-Coding RNAs in Pancreatic Cancer: Biologic Functions, Mechanisms, and Clinical Significance

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2022 May 14

PMID 35565245

Authors

Jiajia Li

Sicong Hou

Ziping Ye

Wujun Wang

Xiaolin Hu

Qinglei Hang

Affiliations

Soon will be listed here.

Abstract

Despite tremendous efforts devoted to research in pancreatic cancer (PC), the mechanism underlying the tumorigenesis and progression of PC is still not completely clear. Additionally, ideal biomarkers and satisfactory therapeutic strategies for clinical application in PC are still lacking. Accumulating evidence suggests that long non-coding RNAs (lncRNAs) might participate in the pathogenesis of diverse cancers, including PC. The abnormal expression of lncRNAs in PC is considered a vital factor during tumorigenesis that affects tumor cell proliferation, migration, invasion, apoptosis, angiogenesis, and drug resistance. With this review of relevant articles published in recent years, we aimed to summarize the biogenesis mechanism, classifications, and modes of action of lncRNAs and to review the functions and mechanisms of lncRNAs in PC. Additionally, the clinical significance of lncRNAs in PC was discussed. Finally, we pointed out the questions remaining from recent studies and anticipated that further investigations would address these gaps in knowledge in this field.

Citing Articles

New insights into tRNA-derived small RNAs in human digestive diseases.

Liu Y, Chen F, Zhang F, Ye Y, Su Y, Liu Y Mol Biol Rep. 2025; 52(1):295.

PMID: 40063289 DOI: 10.1007/s11033-025-10393-7.

RNA-Independent Regulatory Functions of lncRNA in Complex Disease.

Kafida M, Karela M, Giakountis A Cancers (Basel). 2024; 16(15).

PMID: 39123456 PMC: 11311644. DOI: 10.3390/cancers16152728.

Role of Non-coding RNAs on the Radiotherapy Sensitivity and Resistance in Cancer Cells.

Jalali-Zefrei F, Mousavi S, Delpasand K, Shourmij M, Farzipour S Curr Gene Ther. 2024; 25(2):113-135.

PMID: 38676526 DOI: 10.2174/0115665232301727240422092311.

Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer.

Gu X, Minko T Cancers (Basel). 2024; 16(8).

PMID: 38672671 PMC: 11048786. DOI: 10.3390/cancers16081589.

The roles of long non-coding RNAs in Alzheimer's disease diagnosis, treatment, and their involvement in Alzheimer's disease immune responses.

Wu X, Xia P, Yang L, Lu C, Lu Z Noncoding RNA Res. 2024; 9(3):659-666.

PMID: 38577023 PMC: 10987299. DOI: 10.1016/j.ncrna.2024.03.008.

References

Luo Z, Yi Z, Ou Z, Han T, Wan T, Tang Y . RELA/NEAT1/miR-302a-3p/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration. J Cell Physiol. 2018; 234(4):3583-3597. DOI: 10.1002/jcp.27039. View

Lynch C, Tycko B, Bestor T, Walsh C . Reactivation of a silenced H19 gene in human rhabdomyosarcoma by demethylation of DNA but not by histone hyperacetylation. Mol Cancer. 2002; 1:2. PMC: 119368. View

Li L, Zhang G, Chen H, Zhao Z, Chen H, Liu H . Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer. Oncotarget. 2016; 7(44):71773-71781. PMC: 5342121. DOI: 10.18632/oncotarget.12365. View

Yu F, Lu Z, Cai J, Huang K, Chen B, Li G . MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis. Cell Cycle. 2015; 14(24):3885-96. PMC: 4825734. DOI: 10.1080/15384101.2015.1120917. View

Lavie O, Edelman D, Levy T, Fishman A, Hubert A, Segev Y . A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer. Arch Gynecol Obstet. 2017; 295(3):751-761. PMC: 5315703. DOI: 10.1007/s00404-017-4293-0. View

Zou Y, Yao S, Chen X, Liu D, Wang J, Yuan X . LncRNA OIP5-AS1 regulates radioresistance by targeting DYRK1A through miR-369-3p in colorectal cancer cells. Eur J Cell Biol. 2018; 97(5):369-378. DOI: 10.1016/j.ejcb.2018.04.005. View

Meng X, Ma J, Wang B, Wu X, Liu Z . Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway. J Physiol Biochem. 2020; 76(2):301-315. DOI: 10.1007/s13105-020-00734-4. View

Liu Y, Feng W, Gu S, Wang H, Zhang Y, Chen W . The UCA1/KRAS axis promotes human pancreatic ductal adenocarcinoma stem cell properties and tumor growth. Am J Cancer Res. 2019; 9(3):496-510. PMC: 6448060. View

Yang Y, Wen L, Zhu H . Unveiling the hidden function of long non-coding RNA by identifying its major partner-protein. Cell Biosci. 2015; 5:59. PMC: 4618879. DOI: 10.1186/s13578-015-0050-x. View

10.

Wang L, Luan T, Zhou S, Lin J, Yang Y, Liu W . LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p. Cancer Med. 2019; 8(9):4389-4403. PMC: 6675706. DOI: 10.1002/cam4.2335. View

11.

Feng H, Wei B, Zhang Y . Long non-coding RNA HULC promotes proliferation, migration and invasion of pancreatic cancer cells by down-regulating microRNA-15a. Int J Biol Macromol. 2018; 126:891-898. DOI: 10.1016/j.ijbiomac.2018.12.238. View

12.

Ma L, Wang F, Du C, Zhang Z, Guo H, Xie X . Long non-coding RNA MEG3 functions as a tumour suppressor and has prognostic predictive value in human pancreatic cancer. Oncol Rep. 2018; 39(3):1132-1140. DOI: 10.3892/or.2018.6178. View

13.

Wolpin B, Rizzato C, Kraft P, Kooperberg C, Petersen G, Wang Z . Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet. 2014; 46(9):994-1000. PMC: 4191666. DOI: 10.1038/ng.3052. View

14.

Wang K, Liu C, Zhou L, Wang J, Wang M, Zhao B . APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat Commun. 2015; 6:6779. DOI: 10.1038/ncomms7779. View

15.

Oettle H, Neuhaus P, Hochhaus A, Hartmann J, Gellert K, Ridwelski K . Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA. 2013; 310(14):1473-81. DOI: 10.1001/jama.2013.279201. View

16.

Zhang Q, Geng P, Yin P, Wang X, Jia J, Yao J . Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J Cancer Prev. 2013; 14(4):2311-5. DOI: 10.7314/apjcp.2013.14.4.2311. View

17.

Wan L, Sun M, Liu G, Wei C, Zhang E, Kong R . Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression. Mol Cancer Ther. 2016; 15(5):1082-94. DOI: 10.1158/1535-7163.MCT-15-0707. View

18.

Gao Z, Wang J, Chen D, Ma X, Wu Y, Tang Z . Long non-coding RNA GAS5 suppresses pancreatic cancer metastasis through modulating miR-32-5p/PTEN axis. Cell Biosci. 2017; 7:66. PMC: 5715988. DOI: 10.1186/s13578-017-0192-0. View

19.

Clemson C, Hutchinson J, Sara S, Ensminger A, Fox A, Chess A . An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell. 2009; 33(6):717-26. PMC: 2696186. DOI: 10.1016/j.molcel.2009.01.026. View

20.

Zhang Z, Liu F, Yang F, Liu Y . Kockdown of OIP5-AS1 expression inhibits proliferation, metastasis and EMT progress in hepatoblastoma cells through up-regulating miR-186a-5p and down-regulating ZEB1. Biomed Pharmacother. 2018; 101:14-23. DOI: 10.1016/j.biopha.2018.02.026. View